WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652
, LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved, including the right of reproduction in whole or in part in any form ii
INDEX OF TABLES Table 1: 2003 and 2015 Prevalence of Diabetes in the Adult Population Age 20-79 in Western Europe and the United States. Table 2: 2015-2030 Western Europe Peripheral Artery Disease and Critical Limb Ischemia Prevalence in Patients and Table 3: 2015 Western Europe Country Prevalence of Peripheral Artery Disease and Critical Limb Ischemia in the Adult Population Ages 25 and Older. Table 4: 2015 Western Europe Country Incidence of Peripheral Artery Disease and Critical Limb Ischemia in the Adult Population Ages 45 and Older Table 5: Germany 2015-2030 PAD and CLI Patient Prevalence and Number of Critically 9. 10. 12. 13. 14. Table 6: 2010 and 2017 Germany Percent Diabetes Prevalence by Age Group. 15. Table 7: 2015-2030 Germany Peripheral Artery Disease Incidence in the Population Ages 65 and Older. Table 8: 2015-2030 Germany Peripheral Artery Disease Incidence in the Population Ages 25 and Older. Table 9: Italy 2015-2030 PAD and CLI Patient Prevalence and Number of Critically Ischemic 18. 18. 19. Table 10: Italy Population Ages 65 Glucose Status. 20. Table 11: Italy Population Ages 65 PAD Prevalence by Glucose Status. 21. Table 12: Italy Population Ages 65 CLI Prevalence in PAD by Glucose Status. 21. Table 13: Italy Population Ages 45-64 Glucose Status. 21. Table 14: Italy Population Ages 45-64 PAD Prevalence by Glucose Status. 22. Table 15: Italy Population Ages 45-64 CLI Prevalence in PAD by Glucose Status. 22. Table 16: Italy Population Ages 25-44 Glucose Status. 23. Table 17: Italy Population Ages 25-44 PAD Prevalence by Glucose Status. 23. Table 18: United Kingdom 2015-2030 PAD and CLI Patient Prevalence and Number of Critically 26. Table 19: United Kingdom 2010 and 2017 Estimated Diabetes Percent Prevalence by Age Group. 27. 3
Table 20: Spain 2015-2030 PAD and CLI Patient Prevalence and Number of Critically Ischemic 29. Table 21: Spain 2010 and 2017 Estimated Diabetes Percent Prevalence by Age Group. 30. Table 22: France 2015-2030 PAD and CLI Patient Prevalence and Number of Critically Ischemic 33. Table 23: France 2010 and 2017 Estimated Diabetes Percent Prevalence by Age Group. 34. Table 24: The Netherlands 2015-2030 PAD and CLI Patient Prevalence and Number of Critically 37. Table 25: Netherlands 2015 Estimated Diabetes Percent Prevalence by Age Group. 38. Table 26: The Netherlands Prevalence of Peripheral Artery Disease by Age and Glucose Status. 38. Table 27: Portugal 2015-2030 PAD and CLI Patient Prevalence and Number of Critically Table 28: Belgium 2015-2030 PAD and CLI Patient Prevalence and Number of Critically Table 29: Greece 2015-2030 PAD and CLI Patient Prevalence and Number of Critically Ischemic 40. 42. 44. Table 30: Greece Prevalence of Peripheral Artery Disease by Age and Glucose Status. 45. Table 31: Greece 2015 Estimated Diabetes Percent Prevalence by Age Group. 45. Table 32: Sweden 2015-2030 PAD and CLI Patient Prevalence and Number of Critically Table 33: Austria 2015-2030 PAD and CLI Patient Prevalence and Number of Critically Ischemic Table 34: Switzerland 2015-2030 PAD and CLI Patient Prevalence and Number of Critically Table 35: Finland 2015-2030 PAD and CLI Patient Prevalence and Number of Critically Table 36: Denmark 2015-2030 PAD and CLI Patient Prevalence and Number of Critically Table 37: Norway 2015-2030 PAD and CLI Patient Prevalence and Number of Critically 47. 49. 51. 53. 55. 57. 4
INDEX OF FIGURES Figure 1: 2015 Prevalence of PAD and CLI in Western Europe and the United States. 11. 5
CONTACT INFORMATION Research Mary L. Yost President and Senior Analyst Telephone (404) 520-6652 yost@thesagegroup.us Marketing Harrington Witherspoon Senior Vice President Marketing Telephone (404) 816-0746 witherspoon@thesagegroup.us 6